Biometric Fertility Governance.

1. Introduction

Biometric Fertility Governance is a developing legal and ethical concept concerning the collection, analysis, storage and use of biometric, genetic and reproductive-health information to regulate or influence fertility-related decisions.

It examines how governments, hospitals, fertility clinics, assisted reproductive technology (ART) banks, insurers and digital platforms should be permitted to use technologies that identify individuals or assess their reproductive health.

The term is not, by itself, a universally recognised statutory doctrine. Rather, it is an analytical framework connecting constitutional law, reproductive autonomy, data protection, medical ethics, biotechnology regulation and administrative accountability.

Examples include:

Using fingerprints or facial recognition to verify patients at IVF clinics.

Processing biometric identifiers alongside fertility-treatment records.

Using genetic information to assess inherited reproductive risks.

Developing algorithms to predict ovarian response, pregnancy outcomes or fertility-treatment success.

Using reproductive data to determine eligibility for fertility services, insurance or public healthcare.

Monitoring fertility-related information through wearable devices, mobile applications or connected medical equipment.

The central legal question is:

How can institutions use biometric technology in reproductive healthcare without violating bodily autonomy, informational privacy, equality, dignity and the right to make independent reproductive choices?

Indian constitutional law provides important principles for answering this question, although there is no single Supreme Court judgment establishing a comprehensive doctrine specifically called “Biometric Fertility Governance.”

2. Meaning and scope

A. Identity biometrics

Fingerprints, iris patterns and facial images used to verify a patient's identity, prevent record duplication or secure access to clinical records.

B. Genetic and biological information

DNA sequences, genetic variants and other biological measurements relevant to reproductive health. Genetic information is not necessarily biometric data in the narrow legal sense.

C. Fertility analytics

Algorithms that analyse menstrual-cycle patterns, hormone measurements, ovarian reserve indicators or IVF outcomes to support clinical decisions.

D. Governance and accountability

Rules governing consent, lawful collection, access restrictions, accuracy, discrimination, retention, security, human review and remedies for misuse.

An important distinction is that fingerprints used for identity verification, DNA used for genetic testing and menstrual data used for fertility prediction are different categories of information. They may be subject to overlapping but distinct legal requirements.

3. Constitutional foundations in India

A. Article 21: Life, personal liberty and reproductive autonomy

Article 21 of the Constitution protects life and personal liberty. Indian courts have interpreted it to include privacy, dignity, bodily integrity and reproductive choice.

In the biometric-fertility context, this means that technological systems should not unnecessarily interfere with decisions about whether to have children, when to have children or whether to undergo fertility treatment.

A person should not ordinarily be compelled to disclose extensive reproductive information merely because an institution has adopted a convenient digital verification system.

B. Article 14: Equality and non-arbitrariness

Article 14 requires the State to act consistently with constitutional equality and non-arbitrariness.

Suppose a government-funded fertility programme uses a biometric matching system that repeatedly fails for a particular group of patients. Automatically denying those patients access to treatment could raise equality and administrative fairness concerns.

Similarly, an algorithm that disadvantages patients because of disability, age, socioeconomic status or an inadequately validated biological proxy may require legal and clinical scrutiny.

C. Article 19: Relevant freedoms

Depending on the circumstances, Article 19 may protect relevant interests such as professional activity, expression and association. However, its application depends on the specific right invoked and the nature of the restriction.

D. Privacy and informational self-determination

Reproductive data can reveal intimate facts about sexual activity, pregnancy, infertility, miscarriage, genetic risks and family planning. Unauthorised disclosure may expose individuals to stigma, discrimination or coercion.

The constitutional objective is therefore not to prohibit all reproductive-data processing. It is to ensure that collection and use are lawful, necessary, proportionate and consistent with the rights of affected individuals.

4. Leading case laws

The following cases establish the principal legal rules relevant to biometric fertility governance. Some concern reproductive autonomy directly, while others provide broader principles governing privacy, medical consent and biometric identification.

Case 1. Suchita Srivastava v. Chandigarh Administration (2009) 9 SCC 1

Court: Supreme Court of India.

Legal principle: Reproductive autonomy is part of personal liberty under Article 21.

The Court recognised that reproductive choice includes the freedom to procreate and the freedom to refrain from procreation. It emphasised the importance of a woman's privacy, dignity and bodily integrity.

Relevance to biometric fertility governance

Suppose a hospital develops a biometric system that identifies patients as suitable or unsuitable for fertility treatment based on their reproductive profiles. The system cannot replace the patient's own reproductive decision-making with an institutional preference.

The judgment supports the proposition that reproductive decisions must respect individual autonomy. It does not directly decide the legality of fertility biometrics, but its reasoning is relevant when such systems interfere with reproductive choices.

Rule: Technology may support reproductive healthcare, but it should not become a mechanism for coercing reproductive decisions.

Case 2. Justice K.S. Puttaswamy (Retd.) v. Union of India (2017) 10 SCC 1

Court: Supreme Court of India, nine-judge Constitution Bench.

Legal principle: Privacy is a constitutionally protected fundamental right.

The judgment recognised privacy as an aspect of liberty, dignity, autonomy and personal choice. It also identified informational privacy as an important concern in a technology-driven society.

Indian Kanoon+1

 

The Court established a central framework for assessing State interference with privacy:

Legality: The interference must have a basis in law.

Legitimate aim: It must pursue a legitimate governmental objective.

Proportionality: The measure must be appropriately connected to its objective and must not impose unjustified interference.

Application to fertility data

Consider a government programme that requires every woman seeking fertility treatment to submit fingerprints, facial data and detailed reproductive records.

A legal assessment would ask:

Is the collection authorised by law?

Is each category of data genuinely necessary?

Could the objective be achieved using a less intrusive method?

Who can access the data?

How long will the records be retained?

What safeguards protect against disclosure and misuse?

A general desire for administrative convenience would not, by itself, answer these questions.

Important qualification: Puttaswamy does not make all biometric collection unconstitutional. Its legality depends on the applicable law, purpose, safeguards and proportionality of the interference.

Case 3. Justice K.S. Puttaswamy (Retd.) v. Union of India (2019) 1 SCC 1 — Aadhaar judgment

Court: Supreme Court of India, Constitution Bench; judgment delivered on 26 September 2018.

Legal principle: The constitutional assessment of biometric identification requires attention to statutory authority, proportionality, privacy safeguards and the consequences of authentication failures.

The Court upheld the Aadhaar framework in substantial part while invalidating or limiting particular provisions and uses. The opinions also highlighted concerns about data protection, exclusion and the risks associated with centralised biometric systems.

Supreme Court Observer+1

 

Application to fertility governance

This judgment is particularly relevant where an IVF clinic, donor bank or public fertility programme uses Aadhaar authentication.

For example, a patient whose biometric authentication fails should not automatically be presumed to be ineligible for medically indicated treatment. Whether an alternative identification procedure is legally required depends on the governing scheme and applicable law, but reliable safeguards against wrongful exclusion are essential.

A further issue arises if an institution demands Aadhaar when it has no lawful basis to make that demand. The fact that biometric identification is technologically possible does not automatically establish that it is legally permissible.

Rule: Identity verification must not become an unjustified barrier to reproductive healthcare, and sensitive data must not be used beyond its lawful purpose.

Case 4. Devika Biswas v. Union of India (2016) 10 SCC 726

Court: Supreme Court of India.

Legal principle: Reproductive healthcare must respect informed consent, health, dignity and freedom from coercion.

The case concerned unsafe sterilisation practices, inadequate counselling and failures in the provision of reproductive healthcare. The Court stressed that people must be treated with dignity rather than as mere statistics in population-control programmes. It also addressed the dangers of targets that can encourage coercive sterilisation.

Indian Kanoon+1

 

Application to biometric fertility governance

Suppose a public-health authority uses fertility analytics to rank women according to the number of children they have or to identify those who should undergo sterilisation.

Using biometric identification or predictive analytics to make such a programme more efficient would not cure its underlying consent or rights violations.

Likewise, fertility data should not be used to pressure individuals into contraception, sterilisation, pregnancy or fertility treatment.

Rule: Administrative efficiency and population-level statistics cannot override individual reproductive autonomy.

Case 5. R. Rajagopal v. State of Tamil Nadu (1994) 6 SCC 632

Court: Supreme Court of India.

Legal principle: Privacy protects intimate aspects of personal and family life.

The judgment is an important foundation for Indian privacy law. Its reasoning concerning personal information and private life is relevant to the confidentiality of reproductive records, including information concerning motherhood, procreation and family relationships.

Application

If a fertility clinic discloses a patient's infertility diagnosis, donor-conception history or treatment records without lawful justification, the disclosure may raise privacy and confidentiality issues.

The exact legal remedy would depend on the circumstances, including the identity of the disclosing party, the nature of the information and the applicable statutory framework.

Case 6. Shweta Tuteja v. Union of India (25 May 2026)

A recent High Court decision concerning cryopreserved embryos discussed the relationship between reproductive autonomy, decisional privacy, family life and statutory regulation of assisted reproductive technology.

Indian Kanoon+1

 

Relevance

Embryos, fertility-treatment records and associated biological information may be intimately connected with reproductive decisions. Their management can involve difficult questions of consent, continued storage, use and access to treatment.

The decision is relevant to the broader reproductive-autonomy framework, but it should not be misrepresented as a ruling that directly establishes a general legal doctrine governing biometric fertility databases. Its precise holding must be read in light of the facts and statutory provisions before the court.

5. Statutory framework governing fertility data in India

Biometric fertility governance must be assessed under several overlapping legal frameworks.

A. Assisted Reproductive Technology (Regulation) Act, 2021

The Assisted Reproductive Technology (Regulation) Act, 2021 regulates ART clinics and banks, including donor-related procedures, reproductive services and associated safeguards.

Relevant features include:

Registration and regulation of ART clinics and banks.

Regulation of gamete donation and screening.

Restrictions on sex selection.

Rules concerning pre-implantation genetic testing.

Regulatory oversight of assisted reproductive procedures.

The Act restricts pre-implantation genetic testing to screening for known, pre-existing, heritable or genetic diseases, subject to the statutory provisions. It also regulates donor sourcing and screening.

India Code

 

Legal implication: A fertility clinic cannot assume that all genetic or reproductive information can be collected and used for any purpose merely because it operates within the ART sector. The purpose and use of each dataset must be assessed against the Act and other applicable law.

B. Pre-conception and Pre-natal Diagnostic Techniques (Prohibition of Sex Selection) Act, 1994

The PCPNDT Act, 1994 prohibits sex selection and regulates prenatal diagnostic techniques to prevent their misuse for sex determination and related prohibited purposes.

This is particularly important when reproductive analytics, genetic screening or algorithmic embryo assessment could be used to select sex rather than to diagnose or prevent disease.

The existence of sophisticated technology does not create an exemption from these statutory restrictions.

C. Aadhaar Act, 2016

The Aadhaar (Targeted Delivery of Financial and Other Subsidies, Benefits and Services) Act, 2016 regulates Aadhaar identification and authentication, including restrictions on the use and disclosure of identity information.

A fertility clinic's ability to request or use Aadhaar must be evaluated under the applicable provisions and judicial decisions. A clinic should not assume that it can make Aadhaar mandatory simply because it wants to verify patient identity.

D. Digital Personal Data Protection Act, 2023

The Digital Personal Data Protection Act, 2023 is relevant to digital processing of personal data, including identifiable fertility and reproductive-health records, subject to the Act's scope, commencement and applicable exemptions.

Biometric and reproductive information should not be treated as interchangeable categories: the precise statutory treatment depends on the type of information, the processing activity and the applicable legal provisions.

For any real-world compliance assessment, the commencement status of the relevant provisions and the rules in force on the date of processing must be verified. Constitutional privacy protections may also apply independently of the statutory data-protection framework.

6. Core legal principles of biometric fertility governance

The cases and legislation above support several principles for analysing the legality of biometric fertility systems.

1. Informed consent

Patients should receive understandable information about the collection and use of their biometric and reproductive data. Consent to IVF treatment should not automatically be treated as consent to unrelated research, commercial profiling or indefinite data retention.

2. Confidentiality and purpose limitation

Fertility information collected to provide medical treatment should not be repurposed for employment screening, unrelated insurance decisions or commercial advertising without an appropriate legal basis.

3. Proportionality

Institutions should collect only information justified by the relevant medical or administrative objective. Less intrusive alternatives should be considered where constitutionally required.

4. Non-discrimination

Automated fertility assessments should not be used as a substitute for individual clinical judgment or as an unjustified basis for excluding people from treatment.

5. Accountability and review

Institutions should maintain appropriate records of data access, explain consequential decisions, correct errors and provide effective complaint and review mechanisms.

These are principles for evaluating legal compliance, not a claim that every safeguard listed is expressly required in identical form by every Indian statute.

7. Important legal problems and hypothetical disputes

A. Biometric fertility profiling without meaningful consent

Hypothetical: A fertility application collects facial images, menstrual-cycle records and fertility predictions. The company later sells the information to third parties.

The legal questions include whether the collection and disclosure had an adequate legal basis, whether the user received appropriate notice, whether consent was valid where required, and whether the disclosure breached confidentiality or data-protection obligations.

The constitutional reasoning in Puttaswamy and the reproductive-autonomy principles in Suchita Srivastava would be relevant.

B. Algorithmic exclusion from IVF treatment

Hypothetical: An automated system rejects patients based on a predicted probability of pregnancy success, without adequate clinical review or a clear explanation.

Potential issues include arbitrary decision-making, discrimination, inadequate medical assessment and the absence of meaningful review.

Article 14 is particularly relevant if a public authority or State-controlled programme is involved. Private providers may be subject to different legal routes, including statutory obligations, contractual duties and applicable healthcare regulation.

C. Misuse of genetic information

Hypothetical: A clinic uses genetic data collected to identify a heritable disease to rank prospective parents according to perceived genetic desirability.

The legal analysis must distinguish lawful medical screening from impermissible sex selection, unjustified discrimination or uses outside the scope of consent and applicable law.

The ART Act and PCPNDT Act may be relevant, depending on the precise conduct.

D. Biometric authentication failure

Hypothetical: A patient cannot complete fingerprint verification because the scanner fails, and the clinic refuses to release essential treatment records or proceed with an otherwise lawful appointment.

The relevant issues include the clinic's legal authority to insist on that authentication method, available alternative verification procedures, the consequences of exclusion and any applicable duties of care.

The Aadhaar judgment and the broader principles of proportionality and access to services provide relevant guidance.

E. Disclosure of donor or reproductive records

Hypothetical: An employee of a reproductive technology bank leaks identifying information about a gamete donor or a patient.

Potential consequences may include statutory or regulatory action, contractual liability, professional disciplinary proceedings and civil remedies, depending on the facts and the governing confidentiality and data-protection provisions.

The mere fact that a record is stored electronically does not remove the institution's legal responsibilities.

8. Comparative legal perspective

International law provides additional context, although foreign decisions are not automatically binding in India.

JurisdictionRelevant frameworkSignificance
European UnionGeneral Data Protection Regulation (GDPR)Special rules apply to genetic data and biometric data processed for uniquely identifying a person; health data is also specially protected.
United KingdomUK GDPR and Data Protection Act 2018Regulates sensitive personal data and imposes requirements on relevant processing activities.
United StatesHIPAA, where applicable, and state privacy lawsCertain healthcare entities must protect covered health information, while other reproductive and biometric data may be governed by separate laws.

The comparative lesson is that biometric identification, genetic information and reproductive-health information must be analysed according to their specific legal classifications. A dataset may fall into more than one protected category.

9. Accountability framework for fertility clinics and regulators

A legally responsible biometric fertility system should address the following matters.

AreaRecommended governance measure
CollectionDocument the purpose and legal basis for each category of data.
ConsentProvide understandable notices and obtain consent where legally required.
AccessRestrict records to authorised personnel and maintain access logs.
SecurityUse appropriate encryption, access controls and breach-response procedures.
Automated decisionsValidate systems clinically and assess bias, accuracy and limitations.
Human oversightProvide meaningful clinical review of consequential automated decisions.
RetentionEstablish lawful retention periods and secure deletion procedures.
RemediesProvide complaint channels, correction mechanisms and appropriate avenues of review.

For public authorities, the constitutional requirements of legality, legitimate purpose and proportionality are central. For private clinics, the analysis also includes applicable statutory, contractual, professional and data-protection duties.

10. Critical analysis

Biometric fertility governance involves a difficult balance between technological benefits and individual rights.

On the one hand, appropriate technology can improve patient identification, reduce record errors, strengthen laboratory traceability and support clinically useful fertility assessments.

On the other hand, the combination of biometric identifiers, genetic profiles and reproductive histories can create unusually intimate datasets. Misuse may expose patients to stigma, discrimination, coercion or lasting privacy harms.

Three distinctions are particularly important.

First, clinical usefulness does not automatically establish legal necessity. A system may improve administrative efficiency while still collecting more information than is justified.

Second, consent to treatment is not blanket permission for every secondary use of data. Research, commercial use and data sharing may require separate legal analysis.

Third, a prediction is not a determination of reproductive worth. An algorithm's estimate of treatment success should not be confused with a person's entitlement to dignity, autonomy or equal treatment under applicable law.

The appropriate response is not necessarily to prohibit biometric fertility technology. It is to subject its use to legally grounded safeguards, clinical validation, privacy protection and effective accountability.

11. Conclusion

Biometric Fertility Governance is best understood as an emerging analytical framework rather than a standalone, established legal doctrine.

In India, its strongest foundations are the constitutional protection of privacy under K.S. Puttaswamy, reproductive autonomy under Suchita Srivastava, the reproductive-health and consent principles in Devika Biswas, the Aadhaar jurisprudence and the statutory regulation of assisted reproductive technology.

Together, these authorities provide a framework for examining whether fertility-related biometric systems are lawful, proportionate, confidential, non-discriminatory and consistent with individual reproductive autonomy.

The central proposition is that biometric technology may assist reproductive healthcare, but it must not displace informed consent, constitutional dignity, medical judgment or lawful individual choice.

Academic note: The cases discussed establish principles relevant to this subject; they should not be cited as though the Supreme Court has already recognised a separate cause of action or doctrine formally named “Biometric Fertility Governance.”

LawGratis provides pro bono legal aid and resources to empower communities. Join us in making justice reachable for everyone! Follow our community on Instagram, YouTube, Facebook, and LinkedIn.

LEAVE A COMMENT